Pulsed Electric Field Ablation for Metastatic Breast Cancer
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07487844
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pulsed Electric Field (PEF) System — DEVICEPulsed electric field (PEF) delivers short, high frequency electrical pulses that are intended to shrink or destroy tumors
- Questionnaires — BEHAVIORALParticipants will complete health related, quality of life questionnaires
- Tumor Ablation — PROCEDUREUndergo ablation via PEF
Study Details
This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.
Key Dates
- First listed
- Mar 23, 2026
- Start date
- Jun 29, 2026
- Status verified
- Sep 2026
- Primary completion
- Aug 1, 2028
- Completion
- Aug 1, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Image-Guided Pulsed Electric Field (PEF) AblationParticipants undergo a single treatment of PEF ablation delivered to up to 3 soft tissue metastatic breast cancer lesion(s). Ablation parameters, immediate adverse events, and post-ablation imaging will be collected during the ablation treatment.
Primary Outcome Measure
Proportion of participants with treatment-emergent adverse events [ Time Frame: Up to 4 weeks ]
Central Contacts
- Maya Aslam877-827-3222
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94143 | Ryan Kohlbrenner, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
By condition
By specialty
By research site
Related Studies
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruiting · Stanford University · Stanford, California
- Magnetic Resonance Imaging of Breast CancerRecruiting · Stanford University · Stanford, California
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona